D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 901–1,000 of 1,013
Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study
Guennoun, R., & Bloch, B. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90076-n · Cited by 65
Steiner, H., & Waes, V. V. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.10.001 · Cited by 64
Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies
Sharma, S., Singh, S., Sharma, V., Singh, V. P., & Deshmukh, R. R. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.01.029 · Cited by 64
Yu, X., He, G.-R., Sun, L., Lan, X., Shi, L.-L., Xuan, Z.-H., & Du, G.-H. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.005 · Cited by 64
Febo, M., Gonzalez-Rodriguez, L. A., Capó‐Ramos, D. E., González‐Segarra, N. Y., & Segarra, A. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01858.x · Cited by 64
Late degeneration of nigro-striatal neurons in ATM−/− mice
Eilam, R., Peter, Y., Groner, Y., & Segal, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00322-1 · Cited by 64
Valdenaire, O., Maus, M., Vincent, J., Mallet, J. J., & Vernier, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71030929.x · Cited by 64
Taylor, M. D., CEBALLOS, M. L. D., Rose, S., Jenner, P. G., & MARSDEN, C. D. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90295-f · Cited by 64
Behavioural effects of selective tachykinin agonists in midbrain dopamine regions
Stoessl, A. J., Szczutkowski, E., Glenn, B., & Watson, I. (1991) · Brain Research · doi:10.1016/0006-8993(91)91657-m · Cited by 64
Cortico-striatal circuits: novel therapeutic targets for substance use disorders
Kravitz, A. V., Tomasi, D., LeBlanc, K. H., Baler, R., Volkow, N. D., Bonci, A., & Ferré, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.048 · Cited by 63
Pignatelli, M., Tejeda, H. A., Barker, D. J., Bontempi, L., Wu, J., Lopez, A., Ribeiro, S. P., Lucantonio, F., Parise, E. M., Torres‐Berrío, A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0686-8 · Cited by 63
Yoo, J., Yang, E.-M., Lee, S., Loh, H. H., Ho, I. K., & Jang, C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00410-5 · Cited by 63
Yamaguchi, H., Aiba, A., Nakamura, K., Nakao, K., Sakagami, H., Goto, K., Kondo, H., & Katsuki, M. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.d01-238.x · Cited by 53
Fox, S. H., Silverdale, M., Kellett, M., Davies, R., Steiger, M. J., Fletcher, N. A., Crossman, A. R., & Brotchie, J. M. (2003) · Movement Disorders · doi:10.1002/mds.10693 · Cited by 63
Griffon, N., Pilon, C., Sautel, F., Schwartz, J.-C., & Sokoloff, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010001.x · Cited by 63
Narang, N., & Wamsley, J. K. (1995) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(95)00064-e · Cited by 63
Lévy, R., Herrero, M. T., Ruberg, M., Villares, J., Faucheux, B. A., Guridi, J., López-Guillén, J. L., Luquín, M. R., Javoy-Agid, F., Obeso, J. A., et al. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01110.x · Cited by 63
Svensson, A. I., Carlsson, A., & Carlsson, M. L. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250961 · Cited by 63
Gantois, I., Fang, K., Jiang, L., Babovic, D., Lawrence, A. J., Ferreri, V., Teper, Y., Jupp, B., Ziebell, J., Morganti-Kossmann, C. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611625104 · Cited by 62
Interactions of glutamate and dopamine in a computational model of the striatum
K�tter, R., & Wickens, J. R. (1995) · Journal of Computational Neuroscience · doi:10.1007/bf00961434 · Cited by 62
Striatal Direct Pathway Targets Npas1 + Pallidal Neurons
Cui, Q., Du, X., Chang, I. Y. M., Pamukcu, A., Lilascharoen, V., Berceau, B. L., García, D., Hong, D., Chon, U., Narayanan, A., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2306-20.2021 · Cited by 62
Aversive motivation and the maintenance of monogamous pair bonding
Resendez, S. L., & Aragona, B. J. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0068 · Cited by 60
The Striatum and Subthalamic Nucleus as Independent and Collaborative Structures in Motor Control
Tewari, A., Jog, R., & Jog, M. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00017 · Cited by 62
Targeting the dopamine D3 receptor: an overview of drug design strategies
Cortés, A., Moreno, E., Rodríguez-Ruiz, M., Canela, E. I., & Casadó, V. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1185413 · Cited by 62
Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
Berry, A. S., Shah, V. D., Furman, D. J., White III, R. L., Baker, S. L., O’Neil, J. P., Janabi, M., D’Esposito, M., & Jagust, W. J. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.180 · Cited by 57
Girault, J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00006-7 · Cited by 62
Molecular Profiling of Striatonigral and Striatopallidal Medium Spiny Neurons
Lobo, M. K. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)89001-6 · Cited by 62
Distinct regional differences in dopamine-mediated volume transmission
Rice, M. E. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)25017-6 · Cited by 62
The physiological basis of clinical deficits in Parkinson’s disease
McAuley, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00003-0 · Cited by 62
van den Munckhof, P., Gilbert, F., Chamberland, M., Lévesque, D., & Drouin, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03522.x · Cited by 62
Svenningsson, P., & Moine, C. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01840.x · Cited by 62
Kindlundh, A. M. S., Rahman, S., Lindblom, J., & Nyberg, F. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.040 · Cited by 62
Ossowska, K., Konieczny, J., Wardas, J., Pietraszek, M., Kuter, K. Z., Wolfarth, S., & Pilc, A. (2006) · Amino Acids · doi:10.1007/s00726-006-0317-y · Cited by 62
Mitchell, I., Cooper, A. C., Griffiths, M., & Cooper, A. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00455-9 · Cited by 62
Organization and physiology of thesubstantia nigra
Condé, H. (1992) · Experimental Brain Research · doi:10.1007/bf02259099 · Cited by 62
Moehle, M. S., Pancani, T., Byun, N., Yohn, S. E., Wilson, G. H., Dickerson, J. W., Remke, D. H., Xiang, Z., Niswender, C. M., Wess, J., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.12.008 · Cited by 61
The Striatum’s Role in Executing Rational and Irrational Economic Behaviors
Bamford, I. J., & Bamford, N. S. (2019) · The Neuroscientist · doi:10.1177/1073858418824256 · Cited by 61
Update on GPCR-based targets for the development of novel antidepressants
Mantas, I., Saarinen, M., Xu, Z., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01040-1 · Cited by 55
Molecular Imaging Markers to Track Huntington’s Disease Pathology
Wilson, H., Micco, R. D., Niccolini, F., & Politis, M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00011 · Cited by 61
Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear
Bouchet, C. A., Miner, M. A., Loetz, E. C., Rosberg, A. J., Hake, H. S., Farmer, C. E., Ostrovskyy, M., Gray, N. A., & Greenwood, B. N. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.235 · Cited by 61
Osborne, P. G., O'Connor, W. T., Beck, O., & Ungerstedt, U. (1994) · Brain Research · doi:10.1016/0006-8993(94)90254-2 · Cited by 61
Carta, A. R., Pinna, A., Cauli, O., & Morelli, M. (2002) · Synapse · doi:10.1002/syn.10066 · Cited by 61
Modulation of Neurotransmitter Release in the Basal Ganglia of the Rat Brain by Dynorphin Peptides
You, Z.-B., Herrera-Marschitz, M., & Terenius, L. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35036-0 · Cited by 58
Suzuki, K., Harada, A., Suzuki, H., Miyamoto, M., & Kimura, H. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.20 · Cited by 60
Hippocampal-Evoked Feedforward Inhibition in the Nucleus Accumbens
Scudder, S. L., Baimel, C., Macdonald, E. E., & Carter, A. G. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1971-18.2018 · Cited by 60
Dopamine D1 receptor desensitization profile in MPTP-lesioned primates
Blanchet, P. J., Grondin, R., Bédard, P. J., Shiosaki, K., & Britton, D. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00309-3 · Cited by 60
Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits
Ariano, M. A., Larson, E. R., Noblett, K. L., Sibley, D. R., & Levine, M. S. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199708)26:4<400::aid-syn8>3.0.co;2-a · Cited by 60
Self-citationThe putative role of free radicals in the loss of neuronal functioning in senescence
Joseph, J. A. (1992) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02690894 · Cited by 60
Safety out of control: dopamine and defence
Lloyd, K., & Dayan, P. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0099-7 · Cited by 59
The Origin of Abnormal Beta Oscillations in the Parkinsonian Corticobasal Ganglia Circuits
Asadi, A., Asl, M. M., Vahabie, A., & Valizadeh, A. (2022) · Parkinson s Disease · doi:10.1155/2022/7524066 · Cited by 59
The T-type calcium channel as a new therapeutic target for Parkinson’s disease
Yang, Y., Tai, C., Pan, M., & Kuo, C. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1466-6 · Cited by 59
Ophuis, R. J. A. O., Boender, A. J., van Rozen, A. J., & Adan, R. A. H. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00014 · Cited by 59
New genetic insights highlight ‘old’ ideas on motor dysfunction in dystonia
Goodchild, R. E., Grundmann, K., & Pisani, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.09.003 · Cited by 59
Tseng, K. Y., Riquelme, L. A., Belforte, J. E., Pazo, J. H., & Murer, M. G. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00910.x · Cited by 59
Steiner, H., & Kitai, S. T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01756.x · Cited by 59
Daunais, J. B., & McGinty, J. F. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00226-i · Cited by 59
Anatomy, physiology, and pharmacology of the basal ganglia
Pollack, A. E. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70032-3 · Cited by 59
Mapping drug-induced changes in cerebral by Multiple Gradient Recalled Echo functional MRI
Chen, Q., Andersen, A. H., Zhang, Z., Ovadia, A., Gash, D. M., & Avison, M. J. (1996) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)02100-8 · Cited by 59
Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction
Shippenberg, T., LeFevour, A., & Chefer, V. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927813 · Cited by 58
Laprade, N., Radja, F., Reader, T. A., & Soghomonian, J.-J. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-11-03727.1996 · Cited by 58
Watson, J. B., Coulter, P. M., Margulies, J. E., de Lecea, L., Danielson, P. E., Erlander, M. G., & Sutcliffe, J. G. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390113 · Cited by 58
The indirect pathway of the basal ganglia promotes transient punishment but not motor suppression
Isett, B. R., Nguyen, K. P., Schwenk, J. C., Yurek, J. R., Snyder, C. N., Vounatsos, M. V., Adegbesan, K., Ziausyte, U., & Gittis, A. H. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.017 · Cited by 58
Suzuki, K., Harada, A., Shiraishi, E., & Kimura, H. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218552 · Cited by 58
Levodopa delivery systems for the treatment of Parkinson's disease: An overview
Goole, J., & Amighi, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.026 · Cited by 58
Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum
Burkhardt, J. M., Jin, X., & Costa, R. M. (2009) · Frontiers in Integrative Neuroscience · doi:10.3389/neuro.07.028.2009 · Cited by 58
Giorgi, M., Melchiorri, G., Nuccetelli, V., D’Angelo, V., Martorana, A., Sorge, R. P., Castelli, V., Bernardi, G., & Sancesario, G. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.006 · Cited by 58
Mathar, D., Neumann, J., Villringer, A., & Horstmann, A. (2017) · Cortex · doi:10.1016/j.cortex.2017.08.022 · Cited by 58
Hansson, A. C., Gründer, G., Hirth, N., Noori, H. R., Spanagel, R., & Sommer, W. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.010 · Cited by 58
Augustin, S. M., Chancey, J. H., & Lovinger, D. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.042 · Cited by 58
Targeting the cholinergic system in Parkinson’s disease
Liu, C. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0380-z · Cited by 58
Håkansson, K., Lindskog, M., Pozzi, L., Usiello, A., & Fisone, G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.010 · Cited by 58
Blunt, S. B., Jenner, P. G., & MARSDEN, C. D. (1992) · Brain Research · doi:10.1016/0006-8993(92)90147-2 · Cited by 58
Anderson, J. J., Kask, A. M., & Chase, T. N. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00661-3 · Cited by 58
Self-citationExpression of D2 dopamine receptor mRNA in the arterial chemoreceptor afferent pathway
Czyzyk-Krzeska, M., Lawson, E. E., & Millhorn, D. E. (1992) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(92)90124-y · Cited by 58
Rioux, L., Frohna, P., Joyce, J. N., & Schneider, J. S. (1997) · Movement Disorders · doi:10.1002/mds.870120204 · Cited by 58
Pollack, A. E., & Wooten, G. F. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90042-a · Cited by 58
Cazorla, M., Kang, U. J., & Kellendonk, C. (2015) · Movement Disorders · doi:10.1002/mds.26282 · Cited by 57
Striatal CB 1 and D2 receptors regulate expression of each other, CRIP 1A and delta opioid systems
Blume, L. C., Bass, C. E., Childers, S. R., Dalton, G. D., Roberts, D. C. S., Richardson, J. M., Xiao, R., Selley, D. E., & Howlett, A. C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12139 · Cited by 57
Allen, A. T., Maher, K. N., Wani, K. A., Betts, K. E., & Chase, D. L. (2011) · Genetics · doi:10.1534/genetics.111.128512 · Cited by 57
Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
Pisanu, A., Boi, L., Mulas, G., Spiga, S., Fenu, S., & Carta, A. R. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1874-4 · Cited by 57
Ni, Z., Gao, D., Bouali‐Benazzouz, R., Benabid, A. L., & Benazzouz, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01644.x · Cited by 57
Meredith, G. E., Souza, I. E. J. D., Hyde, T. M., Tipper, G., Wong, M. L., & Egan, M. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07798.2000 · Cited by 57
Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas
Pinna, A., Wardas, J., Cristalli, G., & Morelli, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00214-x · Cited by 57
Éthier, I., Beaudry, G., St‐Hilaire, M., Milbrandt, J., Rouillard, C., & Lévesque, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300318 · Cited by 57
Chadha, A., Dawson, L., Jenner, P. G., & Duty, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00413-3 · Cited by 57
Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function
Leslie, C. A., Robertson, M. W., Jung, A. B., Liebermann, J., & Bennett, J. P. (1994) · Synapse · doi:10.1002/syn.890170311 · Cited by 57
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease
Galvan, L., André, V. M., Wang, E. A., Cepeda, C., & Levine, M. S. (2012) · Journal of Huntington's Disease · doi:10.3233/jhd-2012-120009 · Cited by 56
Control of Striatal Signaling by G Protein Regulators
Xie, K., & Martemyanov, K. A. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00049 · Cited by 56
Gene Expression Analyses Identify Narp Contribution in the Development of l-DOPA-Induced Dyskinesia
Charbonnier‐Beaupel, F., Malerbi, M., Alcacer, C., Tahiri, K., Carpentier, W., Wang, C., During, M. J., Xu, D., Worley, P. F., Girault, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5231-13.2015 · Cited by 56
Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum
Isola, R., Zhang, H., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1315-4 · Cited by 56
Díaz-Ruiz, O., Zapata, A. G., Shan, L., Zhang, Y., Tomac, A. C., Malik, N., de la Cruz, F., & Bäckman, C. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007027 · Cited by 56
Vitale, A., Manciocco, A., & Alleva, E. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.006 · Cited by 56
Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum
Barrot, M., Abrous, D. N., Marinelli, M., Rougé‐Pont, F., Le Moal, M., & Piazza, P. V. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01434.x · Cited by 55
Nelson, A. B., Hang, G. B., Grueter, B. A., Pascoli, V., Luscher, C., Malenka, R. C., & Kreitzer, A. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0224-12.2012 · Cited by 55
A Proposed Circuit Computation in Basal Ganglia: History‐Dependent Gain
Yttri, E. A., & Dudman, J. T. (2018) · Movement Disorders · doi:10.1002/mds.27321 · Cited by 53
Neural Activity in Primate Caudate Nucleus Associated With Pro- and Antisaccades
Ford, K. A., & Everling, S. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00125.2009 · Cited by 52
Chergui, K., Svenningsson, P., Nomikos, G. G., Gonon, F., Fredholm, B. B., & Svennson, T. H. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01654.x · Cited by 52
Synaptotagmins in Neurodegeneration
Glavan, G., Schliebs, R., & Živin, M. (2009) · The Anatomical Record · doi:10.1002/ar.21026 · Cited by 51
Investigating striatal function through cell-type-specific manipulations
Kreitzer, A. C., & Berke, J. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.018 · Cited by 48
Ambrose, L. M., Unterwald, E. M., & Van Bockstaele, E. J. (2004) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.20054 · Cited by 48
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.